{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:08:12Z","timestamp":1791083292221,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ecl.2024.05.012","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T22:05:53Z","timestamp":1722290753000},"page":"377-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Update on Preeclampsia and Hypertensive Disorders of Pregnancy"],"prefix":"10.1016","volume":"53","author":[{"given":"Emily A.","family":"Rosenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen W.","family":"Seely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2024.05.012_bib1","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7117a1","article-title":"Hypertensive disorders in pregnancy and mortality at delivery hospitalization \u2014 United States, 2017\u20132019","volume":"71","author":"Ford","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.012_bib2","article-title":"ACOG Practice Bulletin No. 203: chronic hypertension in pregnancy","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ecl.2024.05.012_bib3","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ecl.2024.05.012_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/AOG.0000000000004361","article-title":"Maternal mortality in the United States: recent trends, current status, and future considerations","volume":"137","author":"Joseph","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ecl.2024.05.012_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1144170","article-title":"Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum","volume":"10","author":"Bisson","year":"2023","journal-title":"Front Med"},{"issue":"18","key":"10.1016\/j.ecl.2024.05.012_bib7","doi-asserted-by":"crossref","first-page":"e902","DOI":"10.1161\/CIR.0000000000000961","article-title":"Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the American Heart Association","volume":"143","author":"Parikh","year":"2021","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ecl.2024.05.012_bib8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.012_bib9","doi-asserted-by":"crossref","first-page":"251.e1","DOI":"10.1016\/j.ajog.2021.08.004","article-title":"A\u00a0randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China","volume":"226","author":"Lin","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.012_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ije\/dyx235","article-title":"Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child","volume":"47","author":"Petersen","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"11","key":"10.1016\/j.ecl.2024.05.012_bib11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1471-0528.1995.tb10872.x","article-title":"Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. CLASP collaborative group","volume":"102","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.012_bib12","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"743: Low-dose aspirin use during pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.ecl.2024.05.012_bib13","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1016\/j.ajpath.2016.08.010","article-title":"Low-dose acetylsalicylic acid treatment modulates the production of Cytokines and improves trophoblast function in an in\u00a0vitro model of early-onset preeclampsia","volume":"186","author":"Panagodage","year":"2016","journal-title":"Am J Pathol"},{"issue":"18","key":"10.1016\/j.ecl.2024.05.012_bib14","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.3390\/ijms20184370","article-title":"Molecular targets of aspirin and prevention of preeclampsia and their potential association with circulating extracellular vesicles during pregnancy","volume":"20","author":"Dutta","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ecl.2024.05.012_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2022.100663","article-title":"Assessment of adherence to aspirin for preeclampsia prophylaxis and reasons for nonadherence","volume":"4","author":"Olson","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.012_bib16","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2023.04.039","article-title":"Society for Maternal-Fetal Medicine Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention\u2014quality metric and opportunities for quality improvement","volume":"229","author":"Combs","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.012_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajog.2022.11.1302","article-title":"Association of checklist usage with adherence to recommended prophylactic low-dose aspirin for prevention of preeclampsia","volume":"228","author":"Zhou","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2024.05.012_bib18","article-title":"Quality improvement initiative for aspirin screening and prescription rates for preeclampsia prevention in an outpatient obstetric clinic","author":"Kumar","year":"2022","journal-title":"Am J Perinatol"},{"issue":"2S","key":"10.1016\/j.ecl.2024.05.012_bib19","doi-asserted-by":"crossref","first-page":"S1019","DOI":"10.1016\/j.ajog.2020.10.022","article-title":"Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders","volume":"226","author":"Rana","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.012_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.012_bib21","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.119.12739","article-title":"Randomized interventional study on prediction of preeclampsia\/eclampsia in women with suspected preeclampsia","volume":"74","author":"Cerdeira","year":"2019","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.ecl.2024.05.012_bib22","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200161","article-title":"Circulating angiogenic factor levels in hypertensive disorders of pregnancy","volume":"1","author":"Thadhani","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.ecl.2024.05.012_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s12913-018-3406-1","article-title":"Economic assessment of the use of the sFlt-1\/PlGF ratio test to predict preeclampsia in Germany","volume":"18","author":"Schlembach","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ecl.2024.05.012_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.preghy.2021.10.009","article-title":"Cost effectiveness of the sFlt1\/PlGF ratio test as an adjunct to the current practice of evaluating suspected preeclampsia in the United States","volume":"26","author":"Khosla","year":"2021","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ecl.2024.05.012_bib25","series-title":"Overview | PLGF-based testing to help diagnose suspected preterm pre-eclampsia | Guidance","year":"2022"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.012_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/MNH.0000000000000857","article-title":"Hypertension in pregnancy: what we now know","volume":"32","author":"Gupta","year":"2023","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"9","key":"10.1016\/j.ecl.2024.05.012_bib27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11906-020-01082-w","article-title":"Prevention, diagnosis, and management of hypertensive disorders of pregnancy: a comparison of international guidelines","volume":"22","author":"Sinkey","year":"2020","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.012_bib28","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","article-title":"Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association","volume":"79","author":"Garovic","year":"2022","journal-title":"Hypertension"},{"issue":"9198","key":"10.1016\/j.ecl.2024.05.012_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)08049-0","article-title":"Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis","volume":"355","author":"von Dadelszen","year":"2000","journal-title":"Lancet Lond Engl"},{"issue":"10","key":"10.1016\/j.ecl.2024.05.012_bib30","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"10","author":"Abalos","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ecl.2024.05.012_bib31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1404595","article-title":"Less-tight versus tight control of hypertension in pregnancy","volume":"372","author":"Magee","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.ecl.2024.05.012_bib32","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa2201295","article-title":"Treatment for mild chronic hypertension during pregnancy","volume":"386","author":"Tita","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2024.05.012_bib33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.preghy.2021.05.006","article-title":"Lower blood pressure achieved leads to better pregnant outcomes in non-severe chronic hypertensive pregnant women","volume":"25","author":"Zhang","year":"2021","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"10.1016\/j.ecl.2024.05.012_bib34","first-page":"1269","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertens Dallas Tex 1979"},{"issue":"8","key":"10.1016\/j.ecl.2024.05.012_bib35","doi-asserted-by":"crossref","first-page":"e1119","DOI":"10.1016\/S2214-109X(21)00219-9","article-title":"Blood pressure thresholds in pregnancy for identifying maternal and infant risk: a secondary analysis of Community-Level Interventions for Pre-eclampsia (CLIP) trial data","volume":"9","author":"Bone","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.012_bib37","doi-asserted-by":"crossref","first-page":"B24","DOI":"10.1016\/j.ajog.2022.04.011","article-title":"Electronic address: pubss@mfm.org. Society for Maternal-Fetal Medicine Statement: Antihypertensive therapy for mild chronic hypertension in pregnancy-The Chronic Hypertension and Pregnancy trial","volume":"227","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2024.05.012_bib38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens"},{"issue":"8","key":"10.1016\/j.ecl.2024.05.012_bib39","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/CIRCULATIONAHA.118.036748","article-title":"Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications","volume":"139","author":"Grandi","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ecl.2024.05.012_bib40","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1159\/000508036","article-title":"Hypertensive disorders of pregnancy and risk of cardiovascular disease-related morbidity and mortality: a systematic review and meta-analysis","volume":"145","author":"Wu","year":"2020","journal-title":"Cardiology"},{"issue":"19","key":"10.1016\/j.ecl.2024.05.012_bib41","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jacc.2022.03.335","article-title":"Cardiovascular risk factors mediate the long-term maternal risk associated with hypertensive disorders of pregnancy","volume":"79","author":"Stuart","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ecl.2024.05.012_bib42","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/CIRCRESAHA.122.321228","article-title":"Smooth muscle mineralocorticoid receptor promotes hypertension after preeclampsia","volume":"132","author":"Biwer","year":"2023","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.ecl.2024.05.012_bib43","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jacc.2011.02.005","article-title":"Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association","volume":"57","author":"Mosca","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.012_bib44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/10641955.2016.1154967","article-title":"Improving the postpartum care of women with a recent history of preeclampsia: a focus group study","volume":"35","author":"Skurnik","year":"2016","journal-title":"Hypertens Pregnancy"},{"issue":"6","key":"10.1016\/j.ecl.2024.05.012_bib45","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/AOG.0000000000000856","article-title":"Recognition by Women\u2019s Health Care providers of long-term cardiovascular disease risk after preeclampsia","volume":"125","author":"Wilkins-Haug","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.012_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/10641955.2010.544955","article-title":"Physicians\u2019 knowledge of future vascular disease in women with preeclampsia","volume":"31","author":"Young","year":"2012","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ecl.2024.05.012_bib47","article-title":"Accuracy of maternal self-report of recent preeclampsia among healthy women","author":"Stuart","year":"2002","journal-title":"J\u00a0Womens Health"},{"issue":"25","key":"10.1016\/j.ecl.2024.05.012_bib48","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852924000422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852924000422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T05:27:18Z","timestamp":1722317238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852924000422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0889852924000422"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2024.05.012","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on Preeclampsia and Hypertensive Disorders of Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2024.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}